4//SEC Filing
Abrahmsen Lars B. 4
Accession 0001104659-22-033389
CIK 0001781983other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 5:01 PM ET
Size
7.5 KB
Accession
0001104659-22-033389
Insider Transaction Report
Form 4
Abrahmsen Lars B.
SVP, Chief Scientific Officer
Transactions
- Award
Common Stock
2022-03-10+24,700→ 43,700 total - Award
Stock Option (right to Buy)
2022-03-10+100,000→ 100,000 totalExercise: $1.82Exp: 2032-03-10→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]These shares represent restricted stock units which were granted on March 10, 2022, and which will vest and be settled in common stock as follows: (i) 8,233 shares on March 10, 2023, (ii) 8,233 shares on March 10, 2024 and (iii) 8,234 shares on March 10, 2025, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.
- [F2]Twenty-five percent of these options vest on March 10, 2023, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.
Documents
Issuer
Aprea Therapeutics, Inc.
CIK 0001781983
Entity typeother
Related Parties
1- filerCIK 0001789039
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 5:01 PM ET
- Size
- 7.5 KB